248 related articles for article (PubMed ID: 28802075)
1. Overcoming severe adverse reactions to venom immunotherapy using anti-IgE antibodies in combination with a high maintenance dose.
Stretz E; Oppel EM; Räwer HC; Chatelain R; Mastnik S; Przybilla B; Ruëff F
Clin Exp Allergy; 2017 Dec; 47(12):1631-1639. PubMed ID: 28802075
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis and treatment of Hymenoptera venom allergy: S2k Guideline of the German Society of Allergology and Clinical Immunology (DGAKI) in collaboration with the Arbeitsgemeinschaft für Berufs- und Umweltdermatologie e.V. (ABD), the Medical Association of German Allergologists (AeDA), the German Society of Dermatology (DDG), the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery (DGHNOKC), the German Society of Pediatrics and Adolescent Medicine (DGKJ), the Society for Pediatric Allergy and Environmental Medicine (GPA), German Respiratory Society (DGP), and the Austrian Society for Allergy and Immunology (ÖGAI).
Ruëff F; Bauer A; Becker S; Brehler R; Brockow K; Chaker AM; Darsow U; Fischer J; Fuchs T; Gerstlauer M; Gernert S; Hamelmann E; Hötzenecker W; Klimek L; Lange L; Merk H; Mülleneisen NK; Neustädter I; Pfützner W; Sieber W; Sitter H; Skudlik C; Treudler R; Wedi B; Wöhrl S; Worm M; Jakob T
Allergol Select; 2023; 7():154-190. PubMed ID: 37854067
[TBL] [Abstract][Full Text] [Related]
3. Venom immunotherapy: clinical efficacy, safety and contraindications.
Kosnik M; Korosec P
Expert Rev Clin Immunol; 2015; 11(8):877-84. PubMed ID: 26018865
[TBL] [Abstract][Full Text] [Related]
4. Treatment with a combination of omalizumab and specific immunotherapy for severe anaphylaxis after a wasp sting.
Palgan K; Bartuzi Z; Gotz-Zbikowska M
Int J Immunopathol Pharmacol; 2014; 27(1):109-12. PubMed ID: 24674685
[TBL] [Abstract][Full Text] [Related]
5. Venom immunotherapy and difficulties encountered before and during immunotherapy: Double sensitization, systemic reactions, treatment with omalizumab, and high dose VIT.
Çetin GP; Yılmaz İ; Türk M; Arslan B; Bahçecioğlu SN
Turk J Med Sci; 2022 Aug; 52(4):1223-1234. PubMed ID: 36326412
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy and biologicals for the treatment of allergy to Hymenoptera stings.
Ridolo E; Pellicelli I; Kihlgren P; Nizi MC; Pucciarini F; Senna G; Incorvaia C
Expert Opin Biol Ther; 2019 Sep; 19(9):919-925. PubMed ID: 31190572
[No Abstract] [Full Text] [Related]
7. Omalizumab ensures compatibility to bee venom immunotherapy (VIT) after VIT-induced anaphylaxis in a patient with systemic mastocytosis.
Gülsen A; Ruëff F; Jappe U
Allergol Select; 2021; 5():128-132. PubMed ID: 33733040
[TBL] [Abstract][Full Text] [Related]
8. Predictors of clinical effectiveness of Hymenoptera venom immunotherapy.
Ruëff F; Vos B; Oude Elberink J; Bender A; Chatelain R; Dugas-Breit S; Horny HP; Küchenhoff H; Linhardt A; Mastnik S; Sotlar K; Stretz E; Vollrath R; Przybilla B; Flaig M
Clin Exp Allergy; 2014; 44(5):736-46. PubMed ID: 24447114
[TBL] [Abstract][Full Text] [Related]
9. Venom Immunotherapy: Questions and Controversies.
Golden DBK
Immunol Allergy Clin North Am; 2020 Feb; 40(1):59-68. PubMed ID: 31761121
[TBL] [Abstract][Full Text] [Related]
10. Safety and Effectiveness of a 3-Day Rush Insect Venom Immunotherapy Protocol.
Kranert P; Forchhammer S; Volc S; Stenger F; Schaller M; Fischer J
Int Arch Allergy Immunol; 2020; 181(2):111-118. PubMed ID: 31794966
[TBL] [Abstract][Full Text] [Related]
11. Safety profile of hymenoptera venom immunotherapy (VIT) in monosensitized patients: lack of new sensitization to nontreated insect venom.
Spoerl D; Bircher AJ; Scherer K
J Investig Allergol Clin Immunol; 2011; 21(1):22-7. PubMed ID: 21370719
[TBL] [Abstract][Full Text] [Related]
12. Patients still reacting to a sting challenge while receiving conventional Hymenoptera venom immunotherapy are protected by increased venom doses.
Ruëff F; Wenderoth A; Przybilla B
J Allergy Clin Immunol; 2001 Dec; 108(6):1027-32. PubMed ID: 11742283
[TBL] [Abstract][Full Text] [Related]
13. [Sting challenge: indications and execution].
Ruëff F; Przybilla B
Hautarzt; 2014 Sep; 65(9):796-801. PubMed ID: 25234628
[TBL] [Abstract][Full Text] [Related]
14. Prevention and treatment of hymenoptera venom allergy: guidelines for clinical practice.
Bonifazi F; Jutel M; Biló BM; Birnbaum J; Muller U;
Allergy; 2005 Dec; 60(12):1459-70. PubMed ID: 16266376
[TBL] [Abstract][Full Text] [Related]
15. Rush hymenoptera venom immunotherapy is efficacious and safe.
Pasaoglu G; Sin BA; Misirligil Z
J Investig Allergol Clin Immunol; 2006; 16(4):232-8. PubMed ID: 16889280
[TBL] [Abstract][Full Text] [Related]
16. Hymenoptera venom immunotherapy and field stings.
Lang R; Hawranek T
J Investig Allergol Clin Immunol; 2006; 16(4):224-31. PubMed ID: 16889279
[TBL] [Abstract][Full Text] [Related]
17. Omalizumab and hypersensitivity reactions.
Shankar T; Petrov AA
Curr Opin Allergy Clin Immunol; 2013 Feb; 13(1):19-24. PubMed ID: 23242113
[TBL] [Abstract][Full Text] [Related]
18. [Intolerance of specific immunotherapy with Hymenoptera venom: jumping the hurdle with omalizumab].
Wieczorek D; Kapp A; Wedi B
Hautarzt; 2014 Sep; 65(9):791-5. PubMed ID: 25234627
[TBL] [Abstract][Full Text] [Related]
19. Natural history of Hymenoptera venom allergy in children not treated with immunotherapy.
Lange J; Cichocka-Jarosz E; Marczak H; Krauze A; Tarczoń I; Świebocka E; Lis G; Brzyski P; Nowak-Węgrzyn A
Ann Allergy Asthma Immunol; 2016 Mar; 116(3):225-9. PubMed ID: 26945496
[TBL] [Abstract][Full Text] [Related]
20. Flow-assisted quantification of in vitro activated basophils in the diagnosis of wasp venom allergy and follow-up of wasp venom immunotherapy.
Ebo DG; Hagendorens MM; Schuerwegh AJ; Beirens LM; Bridts CH; De Clerck LS; Stevens WJ
Cytometry B Clin Cytom; 2007 May; 72(3):196-203. PubMed ID: 17111386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
